breath-based diagnostics
SSI Diagnostica Group Acquires Breath Test Maker Gulf Coast Scientific
SSID Group said that the assets acquired in the deal will complement its gastric health portfolio and let it offer a broader range of tests to US labs.
Cystic Fibrosis Foundation Invests $2.3M in Owlstone Medical
The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Top Five Articles on 360Dx Last Week: Qiagen, BioMérieux Lawsuit; T2 Biosystems Post-Mortem; More
Last week, readers were most interested in a story about a lawsuit brought forth by Qiagen against BioMérieux in Germany.
The firm's test will be used to aid the detection of cancer in patients with dense breast tissue, which can be more difficult to analyze with mammography alone.
Owlstone Medical Raises $27M in Series E Round
The UK-based company is developing tests based on a technology that analyzes breath-based biomarkers.
Oct 23, 2024
Oct 10, 2024
Mar 26, 2024
Aug 22, 2023
Aug 16, 2022
Imspex Gains CE-IVD Mark for COVID-19 Breath Test
Jun 22, 2022